CIPO Patents = 4

EPO Patents = 1

Forward Citations = 5

Loading Chart...

5 inventors (with patents filed for the assignee):

Henry Hsu (5 out of 39 patents)

Shikha P Barman (1 out of 30 patents)

Kevin L Ward (1 out of 10 patents)

4. Laszlo Otvos (1 out of 10 patents)

5. Yugang Chen (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12201668 - Adiponectin peptidomimetics formulations (2025-01-21),

2. 11524045 - Peptides for dry eye disease (2022-12-13),

3. 11464825 - Adiponectin peptidomimetics for treating ocular disorders (2022-10-11),

4. 11273197 - Adiponectin peptidomimetics for treating ocular disorders (2022-03-15),

5. 10987401 - Adiponectin peptidomimetics for treating ocular disorders (2021-04-27),

6. 10537608 - Adiponectin peptidomimetics for treating ocular disorders (2020-01-21),

Allysta Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative treatments for rare and serious diseases. With a strong pipeline of potential therapies, Allysta is committed to improving the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#93 in Bellevue, WA

#1,009 in Washington

#43,751 in US

Bellevue, WA, United States of America

Allysta Pharmaceuticals, Inc.

Forward Citations = 5

5 inventors:

Henry Hsu (5 out of 39 patents)

Shikha P Barman (1 out of 30 patents)

Kevin L Ward (1 out of 10 patents)

4. Laszlo Otvos (1 out of 10 patents)

5. Yugang Chen (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com

4 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com